These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3300834)

  • 1. Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis--a comparative study.
    Gibson T; Emery P; Armstrong RD; Crisp AJ; Panayi GS
    Br J Rheumatol; 1987 Aug; 26(4):279-84. PubMed ID: 3300834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression.
    Dawes PT; Fowler PD; Clarke S; Fisher J; Lawton A; Shadforth MF
    Br J Rheumatol; 1986 Feb; 25(1):44-9. PubMed ID: 3942847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do drugs change the course of rheumatoid arthritis?
    Wright V; Amos R
    Br Med J; 1980 Apr; 280(6219):964-6. PubMed ID: 6106520
    [No Abstract]   [Full Text] [Related]  

  • 4. Penicillamine in the treatment of rheumatoid arthritis.
    Camp AV
    J Rheumatol Suppl; 1981; 7():103-6. PubMed ID: 6939871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long term treatment of rheumatoid arthritis. Experiences with D-penicillamine in comparison with gold and immunosuppressive drugs (author's transl)].
    Warnatz H; Scheiffarth F; Gutmann W
    Med Klin; 1975 Sep; 70(38):1509-15. PubMed ID: 810648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled multicenter trial of tiopronin and d-penicillamine for rheumatoid arthritis.
    Pasero G; Pellegrini P; Ambanelli U; Ciompi ML; Colamussi V; Ferraccioli G; Barbieri P; Mazzoni MR; Menegale G; Trippi D
    Arthritis Rheum; 1982 Aug; 25(8):923-9. PubMed ID: 7115451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of chloroquine and D-penicillamine in the treatment of rheumatoid arthritis.
    Muirden KD
    Med J Aust; 1986 Jan; 144(1):32-4, 36-7. PubMed ID: 2867456
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
    Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How reliable is ESR as a measure of disease activity in rheumatoid arthritis treated with hydroxychloroquine?
    Dixon JS; Greenwood M; Bird HA
    Clin Rheumatol; 1988 Jun; 7(2):262-6. PubMed ID: 2901304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-penicillamine in early rheumatoid arthritis: experience from a 2-year double blind placebo controlled study.
    Eberhardt K; Rydgren L; Fex E; Svensson B; Wollheim FA
    Clin Exp Rheumatol; 1996; 14(6):625-31. PubMed ID: 8978957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminatory indices of response of patients with rheumatoid arthritis treated with D-penicillamine.
    Dixon JS; Pickup ME; Lowe JR; Hallett C; Lee MR; Wright V
    Ann Rheum Dis; 1980 Aug; 39(4):301-11. PubMed ID: 7436556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method of comparing the toxicities of disease suppressive agents: possible application to a comparison between D-penicillamine and chloroquine.
    Redda A; Anastassiades T
    Clin Invest Med; 1984; 7(1):65-71. PubMed ID: 6426836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission-inducing drugs in rheumatoid arthritis.
    Anastassiades TP
    Can Med Assoc J; 1980 Feb; 122(4):405-15. PubMed ID: 6768438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiological progression in rheumatoid arthritis: do D-penicillamine and hydroxychloroquine have different effects?
    Scott DL; Greenwood A; Davies J; Maddison PJ; Maddison MC; Hall ND
    Br J Rheumatol; 1990 Apr; 29(2):126-7. PubMed ID: 2182170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of penicillamine on the laboratory parameters in rheumatoid arthritis.
    Jaffe IA
    Arthritis Rheum; 1965 Dec; 8(6):1064-79. PubMed ID: 5884817
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetic interactions of penicillamine in rheumatoid arthritis.
    Seideman P; Lindström B
    J Rheumatol; 1989 Apr; 16(4):473-4. PubMed ID: 2664169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experiences in the treatment of chronic polyarthritis using D-penicillamine (proceedings)].
    Dürrigl T; Pucar I
    Z Rheumatol; 1976; 35 Suppl 4():suppl 464-9. PubMed ID: 983407
    [No Abstract]   [Full Text] [Related]  

  • 18. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
    Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb NJ
    J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective five-year comparison of treatment which included penicillamine with that excluding penicillamine in early rheumatoid arthritis. The Multicentre Trial Group.
    Br J Rheumatol; 1986 May; 25(2):184-92. PubMed ID: 2871887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial.
    Berry H; Liyanage SP; Durance RA; Barnes CG; Berger LA; Evans S
    Br Med J; 1976 May; 1(6017):1052-4. PubMed ID: 773500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.